Luke Joseph Peppone: High-dose vitamin D significantly reduced bone loss in patients with prostate cancer

Luke Joseph Peppone, Associate Professor – Department of Surgery, Cancer Control (SMD), shared the following post on by ACS Journal Cancer on X, adding the following:

“New Publication
High-dose vitamin D significantly reduced bone loss in patients with prostate cancer in our latest clinical trial! A huge team effort by Supriya Mohile, Chunkit Fung, Amber Kleckner, Michelle Janelsins, Jonathan Friedbergand a special thank you to the participants!”

Quoting ACS Journal Cancer’s post:

“New from Luke Joseph Peppone et al | High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.”

Source: Luke Joseph Peppone/X and ACS Journal Cancer/X